1. Interaction Between Genes and Environment in Inherited Lipid Disorders Determines Clinical Presentation

   • Anton F.H. Stalenhoef

   Editorial Board Pages: 271 - 272

2. HDL Genetics: Candidate Genes, Genome Wide Scans and Gene-Environment Interactions

   • Jose M. Ordovas

   OriginalPaper Pages: 273 - 281

3. Lipoprotein Lipase Deficiency—Rare or Common?

   • Valerie Evans
   • John J.P. Kastelein

   OriginalPaper Pages: 283 - 287

4. Familial Hypercholesterolemia from Children to Adults

   • Leiv Ose

   OriginalPaper Pages: 289 - 293

5. Blockade of the Na⁺-Ca²⁺ Exchanger is More Efficient than Blockade of the Na⁺-H⁺ Exchanger for Protection of the Myocardium from Lethal Reperfusion Injury

   • Tomoaki Matsumoto
   • Tetsuji Miura
   • Kazuaki Shimamoto

   OriginalPaper Pages: 295 - 301

6. Dalteparin Sodium (Fragmin®) Administration Following Acute Infarction does not Affect Myocardial Perfusion and Function in Swine

   • Mickey Scheinowitz
   • Yuval Heled
   • Michael Eldar

   OriginalPaper Pages: 303 - 309

7. Functional Antagonism of Different Angiotensin II Type I Receptor Blockers in Human Arteries

   • Lodewijk J. Wagenaar
   • Adriaan A. Voors
   • Wiek H. van Gilst

   OriginalPaper Pages: 311 - 316

8. Effects of Benzyltetrahydropalmatine on Two Components of the Delayed Rectifier K⁺ Current in Guinea Pig Ventricular Myocytes

   • Yang Li
   • Li ying Fu
   • Mingxing Jiang

   OriginalPaper Pages: 317 - 325

9. The Influence of Magnesium on the Electrophysiological Effects of Erythromycin in the Isolated Guinea Pig Heart

   • Andreas Lueger
   • Marianne Brodmann
   • Gerhard Stark

   OriginalPaper Pages: 327 - 333

10. Effects of Procainamide on Transmural Ventricular Repolarisation

    • Lexin Wang
    • Ah. Chot Yong
    • David Kilpatrick

    OriginalPaper Pages: 335 - 339

11. Intima Media Thickness as a Surrogate Marker for Generalised Atherosclerosis

    • Michiel L. Bots
    • D. Egbertus Grobbee

    OriginalPaper Pages: 341 - 351

12. Antihypertensive Medication and Quality of Life—Silent Treatment of a Silent Killer?

    • A. Douglas Bremner

    OriginalPaper Pages: 353 - 364

13. High Dose Lisinopril in Heart Failure: Economic Considerations

    • Silvia M. Ess
    • Thomas F. Lüscher
    • Thomas D. Szucs

    OriginalPaper Pages: 365 - 371